Switch theme
Sign up to access all valuation multiples
Dr Sulaiman Al Habib Medical Services Group is a healthcare operator. The company is engaged in establishing, operating, and managing hospitals, general and specialized medical complexes, dispensaries, health care centers, diagnostics centers as well as radiology centers. It is also involved in the import, wholesale and retail sales of medicines, medical products, cosmetics, and medical supplies and equipment. The company reports in three segments are Hospitals/ Healthcare Facilities, Pharmacies, and HMG Solutions / Others. The majority of the revenue is earned from the Hospitals/ Healthcare Facilities segment.
1993
n/a
LTM Revenue $3.3B
LTM EBITDA $805M
$26.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dr. Sulaiman Al Habib has a last 12-month revenue (LTM) of $3.3B and a last 12-month EBITDA of $805M.
In the most recent fiscal year, Dr. Sulaiman Al Habib achieved revenue of $3.0B and an EBITDA of $800M.
Dr. Sulaiman Al Habib expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr. Sulaiman Al Habib valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | XXX | $3.0B | XXX | XXX | XXX |
| Gross Profit | $1.1B | XXX | $999M | XXX | XXX | XXX |
| Gross Margin | 33% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $805M | XXX | $800M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 27% | XXX | XXX | XXX |
| EBIT | $671M | XXX | $633M | XXX | XXX | XXX |
| EBIT Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $644M | XXX | $618M | XXX | XXX | XXX |
| Net Margin | 20% | XXX | 21% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Dr. Sulaiman Al Habib's stock price is SAR 262 (or $70).
Dr. Sulaiman Al Habib has current market cap of SAR 91.6B (or $24.5B), and EV of SAR 97.7B (or $26.1B).
See Dr. Sulaiman Al Habib trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $26.1B | $24.5B | XXX | XXX | XXX | XXX | $1.84 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Dr. Sulaiman Al Habib has market cap of $24.5B and EV of $26.1B.
Dr. Sulaiman Al Habib's trades at 8.7x EV/Revenue multiple, and 32.6x EV/EBITDA.
Equity research analysts estimate Dr. Sulaiman Al Habib's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dr. Sulaiman Al Habib has a P/E ratio of 38.0x.
See valuation multiples for Dr. Sulaiman Al Habib and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $24.5B | XXX | $24.5B | XXX | XXX | XXX |
| EV (current) | $26.1B | XXX | $26.1B | XXX | XXX | XXX |
| EV/Revenue | 8.0x | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBITDA | 32.4x | XXX | 32.6x | XXX | XXX | XXX |
| EV/EBIT | 38.8x | XXX | 41.2x | XXX | XXX | XXX |
| EV/Gross Profit | 24.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 38.0x | XXX | 39.6x | XXX | XXX | XXX |
| EV/FCF | -197.4x | XXX | -113.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDr. Sulaiman Al Habib's last 12 month revenue growth is 19%
Dr. Sulaiman Al Habib's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Dr. Sulaiman Al Habib's rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr. Sulaiman Al Habib's rule of X is 72% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Dr. Sulaiman Al Habib and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Growth | 18% | XXX | 14% | XXX | XXX | XXX |
| Rule of 40 | 46% | XXX | 46% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 72% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Sulaiman Al Habib acquired XXX companies to date.
Last acquisition by Dr. Sulaiman Al Habib was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr. Sulaiman Al Habib acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Dr. Sulaiman Al Habib founded? | Dr. Sulaiman Al Habib was founded in 1993. |
| Where is Dr. Sulaiman Al Habib headquartered? | Dr. Sulaiman Al Habib is headquartered in Saudi Arabia. |
| Is Dr. Sulaiman Al Habib publicy listed? | Yes, Dr. Sulaiman Al Habib is a public company listed on SAU. |
| What is the stock symbol of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib trades under 4013 ticker. |
| When did Dr. Sulaiman Al Habib go public? | Dr. Sulaiman Al Habib went public in 2020. |
| Who are competitors of Dr. Sulaiman Al Habib? | Similar companies to Dr. Sulaiman Al Habib include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's current market cap is $24.5B |
| What is the current revenue of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12 months revenue is $3.3B. |
| What is the current revenue growth of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Dr. Sulaiman Al Habib? | Current revenue multiple of Dr. Sulaiman Al Habib is 8.0x. |
| Is Dr. Sulaiman Al Habib profitable? | Yes, Dr. Sulaiman Al Habib is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12 months EBITDA is $805M. |
| What is Dr. Sulaiman Al Habib's EBITDA margin? | Dr. Sulaiman Al Habib's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Dr. Sulaiman Al Habib? | Current EBITDA multiple of Dr. Sulaiman Al Habib is 32.4x. |
| What is the current FCF of Dr. Sulaiman Al Habib? | Dr. Sulaiman Al Habib's last 12 months FCF is -$132M. |
| What is Dr. Sulaiman Al Habib's FCF margin? | Dr. Sulaiman Al Habib's last 12 months FCF margin is -4%. |
| What is the current EV/FCF multiple of Dr. Sulaiman Al Habib? | Current FCF multiple of Dr. Sulaiman Al Habib is -197.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
